Fetal Middle Cerebral Artery Doppler in Preterm Births Receiving Magnesium Sulfate for Neuroprotection

• Status: Completed
• Trial end date: 2015-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

Two groups of women with preterm labor will be included. One will receive magnesium sulfate for neuroprotection and the other will receive placebo. Fetal middle cerebral artery Doppler indices will be measured before and after intake of either magnesium sulfate or placebo to find if any significant changes occur in fetal cerebral blood flow.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Treatments: Magnesium Sulfate; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• pregnant women with preterm labor

• gestational age less than 32 weeks

• singleton pregnancy

Exclusion Criteria:

• contraindication or hypersensitivity to magnesium

• preeclampsia

• multiple pregnancy

• intake of magnesium sulfate in this pregnancy before